A dvances in genetic fate mapping techniques have changed our understanding of the origins and fates of vascular smooth muscle cells (VSMCs) in vivo. [1] [2] [3] [4] [5] When considered in its entirety, the vascular system is a large and diverse structure with numerous organ-specific variations. 6, 7 Blood vessel networks are dynamic and adaptive reflecting processes used to build and remodel such networks in the embryo. 8 The smooth muscle composition of these networks is mosaic in origin, 9, 10 yet most of our inducible genetic tools are expressed in all VSMCs and fail to capture VSMC subsets. In this issue of Circulation Research, Roostalu et al 11 report a new approach to fate mapping VSMCs that suggests a way forward for lineage tracking VSMC subsets in vivo. In the process, they identify an intriguing subset of immature VSMCs formed in the embryo that is traced to branch points and bifurcations in disease-prone arteries.
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Combined NG2 and CD146 Expression Marks Early VSMCs
The authors began by searching for genes that uniquely identify the earliest VSMCs that form around the E10.5 dorsal aorta in the mouse embryo. They focused on the expression dynamics of NG2 (neural/glial antigen-2, Cspg4) and CD146 (melanoma cell adhesion molecule [Mcam] Figure  2B ; Roostalu et al 11 ) . When the double transgenic line thus generated is crossed to an Flpo-dependent EGFP reporter line, then individual early differentiating VSMCs that express both NG2 and CD146 are thus tdTomato (red) and EGFP (green), whereas progeny of these double-positive cells that no longer express CD146 because of maturation steps in VSMC development are now only EGFP positive. Thus, by this 2-step tagging sequence, progenitor cell (red and green) can be distinguished from progeny (green only) throughout the life of the animal.
Lineage Tracking Embryonic VSMCs Into Postnatal Artery Wall
Roostalu et al 11 then asked whether progeny of the earliest VSMCs to appear in developing thoracic aorta are maintained throughout vascular development or are replaced by SMC progenitors appearing later in embryogenesis. When labeled at E10.5, a vast majority of VSMC in the descending aorta at P35 were EGFP positive and thus derived from the E10.5 cohort of CD146/NG2-positive VSMCs. This result is consistent with estimates of long half-lives of VSMCs in mouse aorta of 270 to 400 days 12 and the slow turnover of cross-linked elastin that surrounds these VSMCs in the walls of large elastic arteries. 13 Their unique lineage tagging method allowed them to make a surprising observation that although most aortic VSMCs pass through a cranial-to-caudal temporal sequence of differentiation to form mature myocytes that no longer express CD146, a small number of immature VSMCs (both CD146 + and NG2 + ) were found residing at aortic branch sites in 3-month-old adult mice. Although CD146/NG2-doublepositive VSMCs were tracked to branch points, they were not exclusively limited to those structures. Moreover, the authors frequently refer to CD146/NG2-double-positive VSMCs as 
Do Branch Points Contain Functionally Distinct VSMCs?
Blood vessels form branching networks as soon as they appear in embryonic development. 7, 8 Remodeling and pruning of a primitive vascular plexus are critical steps in organogenesis and yet we have little understanding of the mechanisms involved. The resulting architecture of perfusion-distributing networks generates many such branch points throughout the body. The branch points and bifurcations in conduit arteries are themselves subjected to turbulent and pulsing blood flow, high mechanical stress, and accelerated atherosclerosis. Given the need to maintain flow dividers to minimize disturbed flow at branch points, the finding of CD146-and NG2-positive VSMCs at arterial branch points is a particularly intriguing aspect of the Roostalu et al 11 study. Although highly speculative, the possibility that CD146/NG2-double-positive VSMCs at branch points may be predisposed to clonal expansion 3, 14, 15 and VSMC to macrophage reprogramming 1,2 is particularly intriguing. If equivalent cells exist in human arteries, could these cells explain the monoclonal nature of at least some atherosclerotic plaques? 16 Further work using well-characterized mouse atherosclerosis models is needed to evaluate the significance of CD146/NG2-double-positive VSMCs at branch points in disease-prone arteries.
Repair of Moderate Versus Severe Arterial Injury
Using this new genetic tool, Roostalu et al 11 next addressed the origin of intimal cells after moderate injury to the SFA in adult mice. When examined 3 weeks after wire injury, the authors found that a majority of intimal cells came from medial VSMCs that expressed tdTomato and EGFP in the SFA wall before injury. These data agree with studies using Myh11cre ERT2 mice. 17, 18 The authors then examined the origins of new VSMCs in a model of severe arterial injury resulting from a complete bisection of the SFA followed by anastomosis of the severed ends ( Figure 7A 
Questions Going Forward
One important future direction will be to determine the VSMC composition at branch points of the left anterior descending and circumflex coronary arteries, sites that are prone to develop atherosclerosis in humans. Equally important, albeit laborious, would be to use current mouse models of atherosclerosis that produce monoclonal or oligoclonal aortic plaques 3, 15 and apply the CD146/NG2 VSMC labeling model described by Roostalu et al 11 to the origins of these lesions. Because high levels of CD146 expression in bone marrow mesenchymal stromal cells correlate with specification to a VSMC fate in vitro, the possibility that some immature VSMCs at arterial branch points could originate from circulating bone marrow-derived cells should be addressed in future studies. Although branch points contained CD146 + VSMCs, they were not entirely composed of them. How are immature CD146
+ VSMCs maintained at branch points in postnatal arteries and do they have normal roles in ongoing repair of bifurcations and flow dividers? Do adventitial VSMC progenitor cells recapitulate the CD146 + /NG2 + immature stage of VSMC differentiation seen in embryonic arteries? Finally, the triple transgenic approach used here may be able to be applied to other reports of immature SMC subsets 19 or progenitor cells 20 resident in the normal media to verify their existence, determine their origins, and follow their kinetics during arterial repair or disease.
Summary and Conclusions
Roostalu et al 11 developed a novel VSMC lineage tracking model that depends on the expression of 2 marker genes in the same embryonic cell and records the fate of those doublepositive precursor cells throughout vascular development and postnatal life. 11 This approach is likely to advance our understanding of the origins and fates of VSMC subsets in vivo. They identify a CD146-positive immature VSMC-like cell residing at arterial branch points and flow dividers of postnatal conduit arteries highlighting the unique functions of these structures in normal and diseased arteries. Finally, the authors shed light on the role of adventitial VSMC progenitor cells in the repair of severe arterial injury. The logic in development of an artery wall that contains multiple subsets of VSMCs and VSMC progenitor cells may be in a division of labor such that different cell populations can more rapidly and efficiently coordinate maintenance of physiological functions with adaptive and repair responses to a wide range of complex signals normally acting on blood vessels in vivo.
